The global Gamma Knife Market is witnessing steady growth as the rising prevalence of brain tumors, neurological disorders, vascular malformations, and other intracranial conditions increases demand for precise and minimally invasive treatment options. Growing adoption of stereotactic radiosurgery, increasing hospital investments in advanced radiation treatment technologies, and rising preference for outpatient procedures are further supporting market expansion. Continuous advancements in imaging integration, robotic positioning, treatment planning software, and precision radiation delivery are creating new opportunities for gamma knife technology providers.
According to Fortune Business Insights, the global Gamma Knife Market was valued at USD 502.05 million in 2025 and is projected to grow from USD 527.54 million in 2026 to USD 784.06 million by 2034, exhibiting a CAGR of 5.08% during 2026–2034.
Gamma Knife Market Growth Drivers
The rising prevalence of brain tumors and neurological disorders is a major factor driving market growth. Healthcare systems worldwide are witnessing increasing demand for precise treatment of malignant tumors, benign tumors, vascular disorders, and functional neurological conditions. Gamma knife radiosurgery provides highly targeted radiation without requiring conventional open brain surgery, making it an attractive treatment option for suitable patients.
For detailed market insights, visit:
https://www.fortunebusinessinsights.com/gamma-knife-market-117247
Malignant Tumors Hold a Leading Position
Based on indication, the market is segmented into Malignant Tumors, Benign Tumors, Vascular Disorders, Functional Disorders, and Ocular Diseases. Malignant tumors represented the leading indication segment, accounting for approximately 36% of the global market. The increasing prevalence of metastatic brain cancer and aggressive intracranial tumors is supporting demand for targeted radiosurgery.
Gamma knife technology enables physicians to target malignant lesions with concentrated radiation while limiting exposure to surrounding healthy brain tissue. Increasing use of stereotactic radiosurgery within multidisciplinary oncology programs and growing adoption of outpatient treatment models are further supporting the segment.
Benign Tumors Represent a Significant Application Segment
Benign tumors accounted for approximately 24% of the global market. Gamma knife systems are increasingly used to treat conditions such as acoustic neuromas, meningiomas, and pituitary adenomas. The non-invasive nature of radiosurgery and the potential to minimize surgical trauma are encouraging healthcare providers to consider gamma knife treatment for suitable benign intracranial lesions.
AI-Assisted Treatment Planning and Precision Radiosurgery Shape the Market
An important trend in the Gamma Knife Market is the growing adoption of AI-assisted treatment planning, image-guided radiosurgery, and robotic precision systems. Healthcare providers are integrating high-resolution MRI and CT imaging with gamma knife technologies to improve targeting accuracy and treatment efficiency. More than 63% of newly installed radiosurgery systems include automated treatment planning software designed to reduce procedural time and improve targeting efficiency.
Another major trend is the increasing adoption of frameless stereotactic radiosurgery and outpatient treatment models. These technologies can improve patient comfort and provide greater procedural flexibility. Manufacturers are also introducing compact treatment platforms with enhanced radiation shielding and workflow automation capabilities.
Expansion of Precision Oncology Creates New Opportunities
The expansion of precision oncology and specialized outpatient radiosurgery centers is creating significant opportunities for market participants. Healthcare providers are increasingly prioritizing personalized treatment approaches that improve targeting accuracy while reducing radiation exposure to healthy tissues. Gamma knife technology aligns with these objectives through its highly focused radiation delivery capabilities.
Integration of AI-based treatment planning, real-time imaging guidance, robotic positioning systems, and workflow automation is expected to create additional opportunities. Rising demand for non-invasive treatments and shorter recovery periods is likely to support long-term adoption of gamma knife systems.
North America Leads the Regional Market
North America dominated the global Gamma Knife Market with approximately 41% market share in 2025. The region benefits from advanced oncology infrastructure, strong healthcare expenditure, and widespread adoption of precision radiosurgery technologies. Hospitals and cancer institutes across the U.S. and Canada are expanding stereotactic radiosurgery capabilities to address growing neurological treatment requirements.
The U.S. remains a major contributor to the regional market due to its advanced neurosurgical infrastructure and high adoption of precision oncology technologies. More than 90 leading medical centers in the country currently operate dedicated gamma knife radiosurgery systems.
Europe accounted for approximately 29% of the global market. Advanced hospital infrastructure, strong neurosurgical research capabilities, and growing government support for oncology innovation are supporting regional growth. Germany represented approximately 32% of the European market, while the U.K. accounted for approximately 23%.
Asia-Pacific accounted for approximately 22% of the global market. Expanding healthcare infrastructure, increasing cancer incidence, and growing adoption of advanced medical technologies are supporting regional expansion. China represented approximately 39% of the Asia-Pacific market, while Japan accounted for approximately 29%.
Japan's Gamma Knife Market is supported by its advanced healthcare infrastructure, aging population, and strong adoption of precision medical technologies. Increasing demand for minimally invasive neurological treatment, image-guided radiosurgery, and advanced treatment planning systems is expected to create further opportunities in the country.
Competitive Landscape
The Gamma Knife Market includes major companies focusing on stereotactic radiosurgery systems, precision treatment technologies, advanced imaging integration, and treatment planning solutions. Major players include Elekta AB, Varian Medical Systems, Huiheng Medical, Inc., MASEP Medical Science Technology Development (Shenzhen) Co., Ltd., and Akesis Inc.
Among the leading companies, Elekta AB accounted for approximately 46% of the market share, while Varian Medical Systems held approximately 27%, highlighting their strong positions within the competitive landscape.
Companies are increasingly investing in AI-assisted treatment planning, robotic positioning, advanced imaging integration, frameless radiosurgery, compact treatment platforms, and workflow automation to strengthen their competitive positions.
Market Challenges
Despite positive growth prospects, the market faces challenges related to high installation and operational costs. Gamma knife platforms require sophisticated radiation shielding infrastructure, advanced imaging systems, treatment planning software, and specialized facilities, resulting in substantial capital investment for healthcare institutions.
Operational expenses also remain a concern because facilities require highly trained neurosurgeons, radiation oncologists, and medical physicists. Continuous equipment calibration, maintenance, and regulatory compliance can further increase operating costs.
The market also faces challenges related to limited accessibility and shortages of skilled specialists. Gamma knife facilities remain concentrated in urban tertiary hospitals and specialized oncology centers, limiting access for patients in rural and underserved regions. Approximately 39% of healthcare facilities experience difficulties recruiting experienced radiosurgery specialists, according to the report.
Competition from alternative treatment technologies, including proton therapy and linear accelerator-based radiosurgery systems, may also affect market penetration in certain healthcare markets.
Request Sample Report
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/gamma-knife-market-117247
Future Outlook
The increasing adoption of AI-assisted treatment planning, image-guided radiosurgery, robotic positioning systems, frameless treatment approaches, outpatient radiosurgery, and precision oncology will create significant opportunities for market participants. Continued investments in specialized cancer centers and advanced neurosurgical infrastructure are expected to strengthen the long-term market outlook.
What’s Driving Japan’s Market? Discover the Latest Gamma Knife Market Insights.
Top comments (0)